<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="EUR" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>FI-3-2019-2019000413</iati-identifier>
  <reporting-org ref="FI-3" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Ministry for Foreign Affairs of Finland</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Resistomap antibiotic resistance monitoring service in Indonesia</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Resistomap has rare research expertise that enables us to employ a molecular genetic method and high-throughput SmartChip qPCR technology for monitoring the presence and quantity of antibiotic resistance genes from various sources. Resistomap antibiotic re
sistance monitoring service includes:1. DNA extraction from the environmental samples such as but not limited to surface water from river and lake wastewater soil stool and tissue samples2. scalable detection and quantification of 12 to 384 antibiotic resi
stance genes using the SmartChip qPCR technology3. automation of data-analysis and 4. an interactive report of the antibiotic resistance gene profile. To target the antibiotic resistance monitoring market in Indonesia we need local partners to receive and 
register the environmental samples from customers and to perform the DNA extraction. Having local partner(s) is needed because to transport the environmental samples requires Material Transfer of Agreement delivery with dry ice and complex regulations in t
he custom. However if the samples are in the DNA form which means there is no potential dangerous hazardous and living materials the delivery from Indonesia to Finland can be done in a standard international courier service faster cheaper and easier regula
tions in the custom. In Finland the DNA samples can be further processed for the SmartChip qPCR analysis at the Resistomap laboratory.Therefore the proposed project is for feasibility study of Resistomap antibiotic resistance monitoring service in Indonesi
a by making a joint venture/ subsidiary company/ joint project with the Indonesian partners which are institutions that have a certified laboratory to perform molecular genetic methods such as for DNA extraction. The project is divided into three phases or
 objectives:1. To identify the partners2. To study the feasibility of Resistomap services3. To train the local staffs</narrative>
  </description>
  <participating-org ref="FI-3" role="1" type="10">
   <narrative xml:lang="EN">Ministry for Foreign Affairs of Finland</narrative>
  </participating-org>
  <participating-org ref="61004" role="3" type="70">
   <narrative xml:lang="EN">Resistomap Oy</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-10-22" type="2">
   <narrative xml:lang="EN">Actual start date of the activity</narrative>
  </activity-date>
  <activity-date iso-date="2020-12-31" type="3">
   <narrative xml:lang="EN">Planned end date of the activity</narrative>
  </activity-date>
  <recipient-country code="ID" percentage="100"></recipient-country>
  <location ref="Indonesia"></location>
  <sector code="12191" percentage="100" vocabulary="1"></sector>
  <tag code="NA" vocabulary="99" vocabulary-uri="https://um.fi/documents/35732/0/finlands-development-cooperation-appropriations-and-disbursements-1989-2019.pdf/fe42e62c-798c-359f-6180-e7e01fd9d89a?t=1588088517786">
   <narrative xml:lang="EN">NA</narrative>
   <narrative xml:lang="FI">NA</narrative>
  </tag>
  <policy-marker code="5" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="1" significance="1" vocabulary="1">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="1" vocabulary="1">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="1">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="EUR" value-date="2019-01-01">30688</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-10-22"></transaction-date>
   <value currency="EUR" value-date="2019-01-01">30688</value>
  </transaction>
 </iati-activity>
</iati-activities>
